Real-time enrollment status for this liver cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 8:02 AM UTC
| NCT Number | NCT05417932 |
| Recruiting Status | Recruiting |
| Condition | Liver Cancer |
| Phase | PHASE1 |
| Target Enrollment | 46 participants |
| Active Locations | 2 sites in the US |
| Sponsor | SCG Cell Therapy Pte. Ltd. |
| Last Updated on CT.gov | February 18, 2025 (Feb 18, 2025) |
As of July 20, 2026: Clinical trial NCT05417932 is currently recruiting participants. This phase1 study for liver cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by SCG Cell Therapy Pte. Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05417932 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05417932 was last updated Feb 18, 2025 (February 18, 2025). HelloStudys verifies this status automatically.